Long Term Drug Treatment
SurModics, Egen continue to assist in the controlled release term of siRNA complexes SurModics, Inc., a leading provider of drug delivery and modification of the surface technologies to the healthcare industry and Egen, Inc., a privately held biopharmaceutical company focused on the development of fatty nucleic (DNA and RNAi) therapeutics for the treatment of human diseases, is pleased to announce that it has executed a continuation of their collaboration focused on the feasibility long-term …
Lakeview Health Systems Provides First-Class Addiction Treatment
